Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: December 14, 2011

Drug Name	Review Type	Class	Manufacturer
Complera	New Drug Initial Review	HIV	Gilead
Brilinta	New Drug Initial Review	Platelet Aggregation Inhibitor	AstraZeneca
Edarbi	New Drug Initial Review	Angiotensin II Receptor Blocker	Takeda
Daliresp	New Drug Initial Review	PDE4 Inhibitor	Forest
Pradaxa	New Drug Appeal	Direct Thrombin Inhibitor	Boehringer-Ingelheim
Incivek	New Drug Appeal	Hepatitis C	Vertex
Onglyza	New Drug Appeal	DPP-4 Inhibitor	BMS
Latuda	New Drug Appeal	Atypical Antipsychotic	Sunovion
Exelon Patch	PDL Appeal	Alzheimers	Novartis

Footer